Re-emergence of Mycoplasma pneumoniae before and after COVID-19 pandemic in Germany
Empirical treatment of CAP patients often does not include coverage of M. pneumoniae. A more thorough implementation of available surveillance data into clinical routine, respective therapies could be adapted more quickly during epidemic outbreaks of M. pneumoniae infections.
Authors
- Jan Kramer (ORCID: https://orcid.org/0000-0002-4151-1996)
- Sébastien Boutin (ORCID: https://orcid.org/0000-0002-0499-2460)
- Jens Matten
- Jan Rupp (ORCID: https://orcid.org/0000-0001-8722-1233)
- Tobias Siegfried Kramer (ORCID: https://orcid.org/0000-0002-2728-9399)
- Frederike Waldeck (ORCID: https://orcid.org/0000-0002-1692-5521)
Institutions
- University Hospital Schleswig-Holstein (DE)
- Klinikverbund Südwest (DE)
- Krankenhaus Nordwest (DE)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Charité - Universitätsmedizin Berlin (DE)
- University of Lübeck (DE)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2025-03-06
- DOI
- https://doi.org/10.1186/s12879-025-10657-4
- Citations
- 8
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 10.83